Stock SHILPAMED SHILPA MEDICARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Shilpa Medicare Limited NSE India S.E.

Equities

SHILPAMED

INE790G01031

Market Closed - NSE India S.E.
Other stock markets
 07:42:31 2024-04-30 am EDT 		5-day change 1st Jan Change
550.4 INR +2.58% Intraday chart for Shilpa Medicare Limited +2.62% +66.62%
Apr. 18 Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US MT
Apr. 17 Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US
MT
Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit
MT
Shilpa Medicare Gets Board Nod to Launch QIP
MT
Shilpa Medicare's Life Science Arm Names CEO
MT
Shilpa Medicare's New Unit in Hyderabad, India Gets Zero Observations from US FDA
MT
Shilpa Medicare Gets Approval to Market Smoking Cessation Drug in Europe
MT
Transcript : Shilpa Medicare Limited, Q3 2024 Earnings Call, Feb 12, 2024
Shilpa Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Shilpa Medicare Gets Germany's Marketing Approval for Rare Muscles Diseases Drug
MT
Shilpa Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Shilpa Medicare Acquires US-Based Pilnova Pharma
MT
Shilpa Medicare Limited Launches Naturally Derived Option for the Treatment of Oral Mucositis in India Under the Brand Name Oraal
CI
Shilpa Medicare Unit's API Manufacturing Plant Gets Clearance from Japanese Drug Regulator's Inspection
MT
Shilpa Medicare Gets UK Drug Regulator's Nod to Market Drug for Meniere's Syndrome Symptoms
MT
Shilpa Medicare Limited Receives Marketing Authorization from MHRA, UK, for Betahistine Dihydrochloride Orodispersible Films, 24 mg
CI
Shilpa Medicare's Manufacturing Facility in Telangana Gets Clearance from Brazilian Regulator
MT
Transcript : Shilpa Medicare Limited, Q1 2024 Earnings Call, Aug 11, 2023
Shilpa Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Shilpa Medicare Limited Announces Issuance of Redeemable Non-Convertible Debentures for its 2 Wholly Owned Subsidiaries
CI
Shilpa Medicare Gets Regulatory Nod for Pemetrexed Injections
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SHILPAMED Stock
  4. SHILPAMED Stock
  5. News Shilpa Medicare Limited